Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Darren S. Cline currently holds 26,764 shares of SEATTLE GENETICS INC /WA (SGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Darren S. Cline has been a net seller of SGEN stock. They have purchased $93.9K and sold $5.5M worth of shares.
Darren S. Cline's most recent insider trade was on Jun 13, 2024, when they sold 26,764 shares at $0.00 per share.
Darren S. Cline serves as Executive at SEATTLE GENETICS INC /WA (SGEN). They have executed 59 insider transactions totaling $5.6M over their tenure at the company.
Darren S. Cline holds the position of Executive at SEATTLE GENETICS INC /WA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Darren S. Cline has shown a selling trading pattern, with $93.9K in total purchases and $5.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Darren S. Cline was on Dec 13, 2016, when they sold $557.0K worth of SGEN shares. This transaction involved 8,806 shares at $63.25 per share.
Darren S. Cline currently owns 26,764 shares of SEATTLE GENETICS INC /WA (SGEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Darren S. Cline's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Darren S. Cline has 59 Form 4 filings on record as an insider at SEATTLE GENETICS INC /WA.
Set alerts for Darren S. Cline and 40,000+ other insiders.